GREGOR WICK

Dr. Gregor Wick has over 20 years of experience at international consulting companies in Germany, the UK and Austria with a focus on strategic planning, innovation management and venture capital. He is the founder and CEO of Angios GmbH in Innsbruck, which develops vascular organoids and antibodies in partnership with big pharma, biotech and universities in Europe and North America.